Pain Relief Comparison: Pericapsular Nerve Group Versus Quadratus Lumborum Block for Positioning in Femur Fracture Surgery

Launched by AIN SHAMS UNIVERSITY · Apr 4, 2025

Keywords

ClinConnect Summary

This clinical trial is comparing two different methods of providing pain relief for patients undergoing surgery for hip fractures. The study will look at the effectiveness of two types of nerve blocks – the Pericapsular Nerve Group Block (PENG) and the Quadratus Lumborum Block (QLB) – in helping manage pain during the positioning of patients for spinal anesthesia. A total of 42 adults will participate, and they will be divided into two groups to receive one of the two nerve blocks. The researchers will assess pain levels before and after the blocks are given, as well as how soon patients need additional pain relief after surgery.

To be eligible for this study, participants need to be adults over the age of 21 who are scheduled for surgery to fix a hip fracture. They should be in good health overall but can have some minor medical conditions. However, individuals who have certain serious health issues, are on long-term opioid pain medications, or have specific infections or allergies will not be able to participate. Throughout the trial, patients will be monitored for their pain levels and any side effects, ensuring their safety and comfort during the process.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients aging \> 21 years of both sexes.
• • Patients scheduled for fixation of proximal femur fracture under spinal anesthesia.
• • ASA Physical Status Class I, II or ш.
• Exclusion Criteria:
• • Patient refusal to participate.
• • Patients receiving opioids for chronic analgesic therapy.
• • in ability to comprehend the visual analog scale.
• • Coagulopathy ( INR \> 1.4, platelets \< 80000/mm3, or bleeding disorder).
• • Infection at the injection site.
• • Allergy to local anesthetics.
• • Polytroma patients ( e.g., concurrent major thoracic/ abdominal injuries)
• • Severe cardiopulmonary disease (e.g., low fixed cardiac output, NYHA class 3/4).
• • Neurological disease (e.g., peripheral neuropathy, multiple sclerosis).